Patent · US Active

Oncolytic adenoviruses armed with heterologous genes

US11938159B2 · kind B2 · utility

0Cited by
21References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 23, 2020
Grant dateMar 26, 2024
Priority date—
Expiry dateJun 4, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/10343
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to a group B adenovirus comprising a sequence of formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.